Valeant Sued for Alleged Racketeering, Linked to Philidor

The class-action complaint was filed in the U.S. District Court in Manhattan
Aug. 30, 2016

Valeant Pharmaceuticals International was sued by drug buyers who charged the company with racketeering by forcing them to pay extremely high prices, according to a Reuters article.

The plaintiffs, unionized New York City police detectives and hotel workers, accused Valeant of violating the U.S. Racketeer Influenced and Corrupt Organizations Act, and seeks compensatory and triple damages for U.S. health plans and others that bought its drugs from January 2013 to October 2015, the story said.

Read the Reuters article

Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates